Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Development of a replicating plasmid based on the native oriC in Mycoplasma pneumoniae.

Blötz C, Lartigue C, Valverde Timana Y, Ruiz E, Paetzold B, Busse J, Stülke J.

Microbiology. 2018 Sep 25. doi: 10.1099/mic.0.000711. [Epub ahead of print]

PMID:
30252643
2.

Cloning and Transplantation of the Mesoplasma florum Genome.

Baby V, Labroussaa F, Brodeur J, Matteau D, Gourgues G, Lartigue C, Rodrigue S.

ACS Synth Biol. 2018 Jan 19;7(1):209-217. doi: 10.1021/acssynbio.7b00279. Epub 2017 Oct 3.

PMID:
28893065
3.

Proteolytic Post-Translational Processing of Adhesins in a Pathogenic Bacterium.

Dubrana MP, Guéguéniat J, Bertin C, Duret S, Arricau-Bouvery N, Claverol S, Lartigue C, Blanchard A, Renaudin J, Béven L.

J Mol Biol. 2017 Jun 16;429(12):1889-1902. doi: 10.1016/j.jmb.2017.05.004. Epub 2017 May 10.

PMID:
28501585
4.

Cloning, Stability, and Modification of Mycoplasma hominis Genome in Yeast.

Rideau F, Le Roy C, Descamps ECT, Renaudin H, Lartigue C, Bébéar C.

ACS Synth Biol. 2017 May 19;6(5):891-901. doi: 10.1021/acssynbio.6b00379. Epub 2017 Feb 7.

PMID:
28118540
5.

Impact of donor-recipient phylogenetic distance on bacterial genome transplantation.

Labroussaa F, Lebaudy A, Baby V, Gourgues G, Matteau D, Vashee S, Sirand-Pugnet P, Rodrigue S, Lartigue C.

Nucleic Acids Res. 2016 Sep 30;44(17):8501-11. doi: 10.1093/nar/gkw688. Epub 2016 Aug 3.

6.

Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol.

Balestrino D, Quintana M, Charbonnel N, Forestier C, Lartigue C, Souweine B.

PLoS One. 2016 Jul 21;11(7):e0159475. doi: 10.1371/journal.pone.0159475. eCollection 2016.

7.

Complete Genome Sequence of Mycoplasma mycoides subsp. mycoides T1/44, a Vaccine Strain against Contagious Bovine Pleuropneumonia.

Gourgues G, Barré A, Beaudoing E, Weber J, Magdelenat G, Barbe V, Schieck E, Jores J, Vashee S, Blanchard A, Lartigue C, Sirand-Pugnet P.

Genome Announc. 2016 Apr 14;4(2). pii: e00263-16. doi: 10.1128/genomeA.00263-16.

8.

Anticoagulant properties of enoxaparin 400 IU/mL-40 % ethanol catheter lock solution.

Calvet L, Piot M, Lartigue C, Souweine B, Tardy-Poncet B.

Springerplus. 2015 Dec 1;4:746. doi: 10.1186/s40064-015-1533-2. eCollection 2015.

9.

In-Yeast Engineering of a Bacterial Genome Using CRISPR/Cas9.

Tsarmpopoulos I, Gourgues G, Blanchard A, Vashee S, Jores J, Lartigue C, Sirand-Pugnet P.

ACS Synth Biol. 2016 Jan 15;5(1):104-9. doi: 10.1021/acssynbio.5b00196. Epub 2015 Dec 7.

PMID:
26592087
10.

Galactofuranose in Mycoplasma mycoides is important for membrane integrity and conceals adhesins but does not contribute to serum resistance.

Schieck E, Lartigue C, Frey J, Vozza N, Hegermann J, Miller RA, Valguarnera E, Muriuki C, Meens J, Nene V, Naessens J, Weber J, Lowary TL, Vashee S, Feldman MF, Jores J.

Mol Microbiol. 2016 Jan;99(1):55-70. doi: 10.1111/mmi.13213. Epub 2015 Oct 14.

11.

TREC-IN: gene knock-in genetic tool for genomes cloned in yeast.

Chandran S, Noskov VN, Segall-Shapiro TH, Ma L, Whiteis C, Lartigue C, Jores J, Vashee S, Chuang RY.

BMC Genomics. 2014 Dec 24;15:1180. doi: 10.1186/1471-2164-15-1180.

12.

The flavoprotein Mcap0476 (RlmFO) catalyzes m5U1939 modification in Mycoplasma capricolum 23S rRNA.

Lartigue C, Lebaudy A, Blanchard A, El Yacoubi B, Rose S, Grosjean H, Douthwaite S.

Nucleic Acids Res. 2014 Jul;42(12):8073-82. doi: 10.1093/nar/gku518. Epub 2014 Jun 17.

13.

Complementary mass spectrometric approaches and scanning electron microscopy to study the structural stability of polyurethane tunneled dialysis catheters after exposure to ethanol solutions.

Msakni N, Galmier MJ, Couret MJ, Szczepaniak C, Bouchon B, Souweine B, Lartigue C.

Rapid Commun Mass Spectrom. 2013 Nov 15;27(21):2343-54. doi: 10.1002/rcm.6691.

PMID:
24097390
14.

A Type III restriction-modification system in Mycoplasma mycoides subsp. capri.

Algire MA, Montague MG, Vashee S, Lartigue C, Merryman C.

Open Biol. 2012 Oct;2(10):120115. doi: 10.1098/rsob.120115.

15.

Synthetic genomics: potential and limitations.

Montague MG, Lartigue C, Vashee S.

Curr Opin Biotechnol. 2012 Oct;23(5):659-65. doi: 10.1016/j.copbio.2012.01.014. Epub 2012 Feb 17. Review.

PMID:
22342755
16.

Creation of a bacterial cell controlled by a chemically synthesized genome.

Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA 3rd, Smith HO, Venter JC.

Science. 2010 Jul 2;329(5987):52-6. doi: 10.1126/science.1190719. Epub 2010 May 20.

17.

Cloning whole bacterial genomes in yeast.

Benders GA, Noskov VN, Denisova EA, Lartigue C, Gibson DG, Assad-Garcia N, Chuang RY, Carrera W, Moodie M, Algire MA, Phan Q, Alperovich N, Vashee S, Merryman C, Venter JC, Smith HO, Glass JI, Hutchison CA 3rd.

Nucleic Acids Res. 2010 May;38(8):2558-69. doi: 10.1093/nar/gkq119. Epub 2010 Mar 7.

18.

Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus.

Chezal JM, Paeshuyse J, Gaumet V, Canitrot D, Maisonial A, Lartigue C, Gueiffier A, Moreau E, Teulade JC, Chavignon O, Neyts J.

Eur J Med Chem. 2010 May;45(5):2044-7. doi: 10.1016/j.ejmech.2010.01.023. Epub 2010 Jan 20.

PMID:
20149501
19.

Creating bacterial strains from genomes that have been cloned and engineered in yeast.

Lartigue C, Vashee S, Algire MA, Chuang RY, Benders GA, Ma L, Noskov VN, Denisova EA, Gibson DG, Assad-Garcia N, Alperovich N, Thomas DW, Merryman C, Hutchison CA 3rd, Smith HO, Venter JC, Glass JI.

Science. 2009 Sep 25;325(5948):1693-6. doi: 10.1126/science.1173759. Epub 2009 Aug 20.

20.

New selectable marker for manipulating the simple genomes of Mycoplasma species.

Algire MA, Lartigue C, Thomas DW, Assad-Garcia N, Glass JI, Merryman C.

Antimicrob Agents Chemother. 2009 Oct;53(10):4429-32. doi: 10.1128/AAC.00388-09. Epub 2009 Aug 17.

21.

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

Desbois N, Gardette M, Papon J, Labarre P, Maisonial A, Auzeloux P, Lartigue C, Bouchon B, Debiton E, Blache Y, Chavignon O, Teulade JC, Maublant J, Madelmont JC, Moins N, Chezal JM.

Bioorg Med Chem. 2008 Aug 15;16(16):7671-90. doi: 10.1016/j.bmc.2008.07.015. Epub 2008 Jul 10.

PMID:
18656367
22.

New opportunities with the Duff reaction.

Masurier N, Moreau E, Lartigue C, Gaumet V, Chezal JM, Heitz A, Teulade JC, Chavignon O.

J Org Chem. 2008 Aug 1;73(15):5989-92. doi: 10.1021/jo800700b. Epub 2008 Jul 3.

PMID:
18597528
23.

Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

Chezal JM, Papon J, Labarre P, Lartigue C, Galmier MJ, Decombat C, Chavignon O, Maublant J, Teulade JC, Madelmont JC, Moins N.

J Med Chem. 2008 Jun 12;51(11):3133-44. doi: 10.1021/jm701424g. Epub 2008 May 16.

PMID:
18481842
24.

Genome transplantation in bacteria: changing one species to another.

Lartigue C, Glass JI, Alperovich N, Pieper R, Parmar PP, Hutchison CA 3rd, Smith HO, Venter JC.

Science. 2007 Aug 3;317(5838):632-8. Epub 2007 Jun 28.

25.

Being pathogenic, plastic, and sexual while living with a nearly minimal bacterial genome.

Sirand-Pugnet P, Lartigue C, Marenda M, Jacob D, Barré A, Barbe V, Schenowitz C, Mangenot S, Couloux A, Segurens B, de Daruvar A, Blanchard A, Citti C.

PLoS Genet. 2007 May 18;3(5):e75.

26.

Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60% ethanol solution.

Guenu S, Heng AE, Charbonné F, Galmier MJ, Charlès F, Deteix P, Souweine B, Lartigue C.

Rapid Commun Mass Spectrom. 2007;21(2):229-36.

PMID:
17171773
27.

Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or "TEER, a measurement of toxicity?".

Mathieu F, Galmier MJ, Pognat JF, Lartigue C.

Eur J Drug Metab Pharmacokinet. 2005 Jan-Jun;30(1-2):85-90.

PMID:
16010866
28.

Identification of degradation products of diclofenac by electrospray ion trap mass spectrometry.

Galmier MJ, Bouchon B, Madelmont JC, Mercier F, Pilotaz F, Lartigue C.

J Pharm Biomed Anal. 2005 Jul 15;38(4):790-6. Epub 2005 Mar 17.

PMID:
15967311
29.

Versatile use of oriC plasmids for functional genomics of Mycoplasma capricolum subsp. capricolum.

Janis C, Lartigue C, Frey J, Wróblewski H, Thiaucourt F, Blanchard A, Sirand-Pugnet P.

Appl Environ Microbiol. 2005 Jun;71(6):2888-93.

30.

New 3- and 4-hydroxyfuranones as anti-oxidants and anti-inflammatory agents.

Weber V, Rubat C, Duroux E, Lartigue C, Madesclaire M, Coudert P.

Bioorg Med Chem. 2005 Jul 15;13(14):4552-64.

PMID:
15908218
31.

Learning from education to communicate science as a good story.

Negrete A, Lartigue C.

Endeavour. 2004 Sep;28(3):120-4. Review.

PMID:
15350764
32.

Host specificity of mollicutes oriC plasmids: functional analysis of replication origin.

Lartigue C, Blanchard A, Renaudin J, Thiaucourt F, Sirand-Pugnet P.

Nucleic Acids Res. 2003 Nov 15;31(22):6610-8.

33.

Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a "dynamic model".

Mathieu F, Galmier MJ, Nicolay A, Pognat JF, Lartigue C.

Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):155-60.

PMID:
12877575
34.

Isotopic effect study of propofol deuteration on the metabolism, activity, and toxicity of the anesthetic.

Helfenbein J, Lartigue C, Noirault E, Azim E, Legailliard J, Galmier MJ, Madelmont JC.

J Med Chem. 2002 Dec 19;45(26):5806-8.

PMID:
12477364
35.

New plasmid vectors for specific gene targeting in Spiroplasma citri.

Lartigue C, Duret S, Garnier M, Renaudin J.

Plasmid. 2002 Sep;48(2):149-59.

PMID:
12383732
36.

Identification of the origin of replication of the Mycoplasma pulmonis chromosome and its use in oriC replicative plasmids.

Cordova CM, Lartigue C, Sirand-Pugnet P, Renaudin J, Cunha RA, Blanchard A.

J Bacteriol. 2002 Oct;184(19):5426-35.

37.

Tank treading and unbinding of deformable vesicles in shear flow: determination of the lift force.

Abkarian M, Lartigue C, Viallat A.

Phys Rev Lett. 2002 Feb 11;88(6):068103. Epub 2002 Jan 25.

PMID:
11863856
38.

Heterocyclization of functionalized vinylic derivatives of imidazo.

Chezal JM, Moreau E, Delmas G, Gueiffier A, Blache Y, Grassy G, Lartigue C, Chavignon O, Teulade JC.

J Org Chem. 2001 Oct 5;66(20):6576-84.

PMID:
11578207
39.

[Esophageal bezoar resulting from nasogastric enteral feeding in an intensive care unit].

Lartigue C, Karayan J, Beau P, Kaffy F.

Ann Fr Anesth Reanim. 2001 Apr;20(4):374-7. French.

PMID:
11392248
40.

Motion of phospholipidic vesicles along an inclined plane: sliding and rolling.

Abkarian M, Lartigue C, Viallat A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Apr;63(4 Pt 1):041906. Epub 2001 Mar 27.

PMID:
11308876
41.

High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor.

Galmier MJ, Frasey AM, Meski S, Beyssac E, Petit J, Aiache JM, Lartigue C.

Biomed Chromatogr. 2000 May;14(3):202-4.

PMID:
10850625
42.

Validation of a reversed-phase liquid chromatographic method for the determination of hydrocortisone phosphate disodium in a gel formulation.

Galmier MJ, Beyssac E, Petit J, Aiache JM, Lartigue C.

J Pharm Biomed Anal. 1999 Jun;20(1-2):405-9. No abstract available.

PMID:
10704050
43.

Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using two media, DMEMc and HBSS.

Mathieu F, Galmier MJ, Pognat JF, Petit J, Lartigue C.

Int J Pharm. 1999 Apr 30;181(2):203-17.

PMID:
10370216
44.

[Esophageal atresia: caring for the child and its family].

Lartigue C.

Rev Infirm. 1997 Jul;(29):13-7. French. No abstract available.

PMID:
9283489
45.

NMR approach to the dynamic screening effect in highly entangled polymers: polyethylene oxide.

Cohen Addad JP, Guillermo A, Lartigue C.

Phys Rev Lett. 1995 May 8;74(19):3820-3823. No abstract available.

PMID:
10058305
46.

[Transfusion-associated HIV contamination between January 1980 and September 1985].

Mesz M, Desbordes JM, Lartigue C, Maissin F, Deglaire B, Fusciardi J.

Ann Fr Anesth Reanim. 1994;13(1):23-6. French.

PMID:
8092578
47.

Measurement of the dynamics of a two-dimensional dislocation-mediated melting.

Simon C, Rosenman I I, Batallan F, Lartigue C, Legrand JF.

Phys Rev B Condens Matter. 1992 Feb 1;45(6):2694-2698. No abstract available.

PMID:
10001815
48.

Identification of several human urinary metabolites of 6-benzoyl benzoxazolinone by gas chromatography/mass spectrometry.

Bastide M, Chabard JL, Lartigue C, Bargnoux H, Petit J, Berger JA, Mansour HA, Lesieur D, Buch N.

Biol Mass Spectrom. 1991 Aug;20(8):484-92.

PMID:
1768705
49.

Adolescent suicide. Risk factors and prevention.

Lartigue EK, Lartigue C.

J Fla Med Assoc. 1990 Aug;77(8):745-7. Review. No abstract available.

PMID:
2254740
50.

Direct microscopic observation of the entanglement distance in a polymer melt.

Richter D, Farago B, Fetters LJ, Huang JS, Ewen B, Lartigue C.

Phys Rev Lett. 1990 Mar 19;64(12):1389-1392. No abstract available.

PMID:
10041383

Supplemental Content

Loading ...
Support Center